- Research Letter
- Open Access
Nasopharyngeal viral load predicts hypoxemia and disease outcome in admitted COVID-19 patients
Critical Care volume 24, Article number: 539 (2020)
The SARS-CoV-2 pandemic imposes an unprecedented burden on hospitals treating coronavirus disease 2019 (COVID-19) patients. Thus, clinical parameters accurately predicting disease outcome are needed. Here, we identified a correlation between viral load measured around admission, lung inflammation, and disease outcome. Similarities and differences between related studies are discussed.
Viral loads of COVID-19 patients admitted to Rabin Medical Center between March 16 and July 23, 2020, were analyzed (n = 170, females 42%, age 62 (IQR 46–73), hospitalization length 7.5 days (IQR 3–13)). Clinical and demographic data were collected from the patients’ electronic medical records. Nasopharyngeal samples were collected and transferred to the microbiology laboratory for testing. Quantitative RT-PCR was performed using the Allplex™ 2019-nCoV Assay (Seegene). Presented are Ct values of the nucleocapsid N gene from the first test performed for each patient. Simple linear regression of clinical parameters against the viral load was fitted to the data to assess the association between viral and clinical parameters using GraphPad Prism. Adjusted odds ratio (OR) of mechanical ventilation and mortality were calculated for each significant variable with 95% confidence intervals (CI) using SPSS, version 26.
Cycle threshold values of the first test performed for all admitted COVID-19 patients were correlated with the patients’ clinical parameters. Among the parameters tested (lowest values of albumin, lymphocyte count, blood oxygen saturation (BOS) and systolic blood pressure, peak levels of lactate dehydrogenase (LDH), C-reactive protein (CRP), ferritin, white blood cell count, and fever), only BOSmin (R = 0.07, p = 0.0004) showed significant correlation (Fig. 1). Interestingly, patients’ age was also significantly correlated with viral load (Fig. 1). Non-survivors and mechanically ventilated patients (n = 21) had a significantly higher viral load (8-folds, Ct = 23.43 ± 5.38) compared to surviving non-intubated patients (n = 149, Ct = 29 ± 5.55, t test p < 0.0001, Fig. 2). A multivariate analysis adjusted for age, gender, and BOSmin revealed that low viral load was independently associated with reduced risk for mechanical ventilation and mortality (OR = 0.90, 95% CI 0.81–0.99, p = 0.046). Furthermore, BOS and patients’ age were also independently associated with mechanical ventilation and death (OR = 0.91, 95% CI 0.84–0.98, p = 0.009 for BOS and OR = 1.05, 95% CI 1.004–1.097 for age).
Our results show a direct link between nasopharyngeal viral load and hypoxemia, as well as worse disease outcomes in admitted patients with COVID-19. Previous studies tested the association between viral load and survival. In agreement with our results, a study of 678 admitted patients in New York found that 35.0% of patients with a high viral load on admission died, compared to 6.2% of patients with low viral loads . In an older age cohort (n = 48, age 67–97) from Belgium, clinical frailty scale, LDH, and viral load predicted survival . Intensive care unit (ICU) admission also positively correlated with detectable viral RNA in anal swabs . In contrast, a Swiss study found no correlation between viral load and disease outcome. The study compared the viral load of patients admitted to the ICU (n = 48) to patients treated in a screening unit (n = 723) . It is not clear, however, whether these patients were later admitted, intubated, or survived. A different New York study (n = 205) found no association between viral load and disease severity parameters. However, this study mainly compared non-hospitalized to hospitalized patients . Several markers were associated with COVID-19 severity, the most accepted is IL-6 . However, IL-6 is not routinely tested at admission and might reflect other inflammatory conditions. Thus, in spite of differences in test kits and procedures between different laboratories and institutions, viral load might provide a rapid screening tool for COVD-19 severity among admitted patients.
Availability of data and materials
The dataset supporting the conclusions of this article is available from the authors upon request.
Severe acute respiratory syndrome coronavirus 2
Coronavirus disease 2019
Reverse transcription polymerase chain reaction
Blood oxygen saturation
Intensive care unit
Magleby R, Westblade LF, Trzebucki A, Simon MS, Rajan M, Park J, Goyal P, Safford MM, Satlin MJ. Impact of SARS-CoV-2 viral load on risk of intubation and mortality among hospitalized patients with coronavirus disease 2019. Clin Infect Dis. 2020;ciaa851, https://doi.org/10.1093/cid/ciaa851.
De Smet R, Mellaerts B, Vandewinckele H, Lybeert P, Frans E, Ombelet S, Lemahieu W, Symons R, Ho E, Frans J, et al. Frailty and mortality in hospitalized older adults with COVID-19: retrospective observational study. J Am Med Dir Assoc. 2020;21(7):928–32 e921.
Lin W, Xie Z, Li Y, Li L, Wen C, Cao Y, Chen X, Ou X, Hu F, Li F, et al. Association between detectable SARS-COV-2 RNA in anal swabs and disease severity in patients with coronavirus disease 2019. J Med Virol. 2020;1–9.
Jacot D, Greub G, Jaton K, Opota O. Viral load of SARS-CoV-2 across patients and compared to other respiratory viruses. medRxiv. 2020:2020.2007.2015.20154518. https://doi.org/10.1101/2020.07.15.20154518.
Argyropoulos KV, Serrano A, Hu J, Black M, Feng X, Shen G, Call M, Kim MJ, Lytle A, Belovarac B, et al. Association of initial viral load in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) patients with outcome and symptoms. Am J Pathol. 2020;190(9):1881–1887.
Liu T, Zhang J, Yang Y, Ma H, Li Z, Zhang J, Cheng J, Zhang X, Zhao Y, Xia Z, et al. The role of interleukin-6 in monitoring severe case of coronavirus disease 2019. EMBO Mol Med. 2020;12(7):e12421.
EHS acknowledges the Milner Foundation for its support.
No funding to declare.
Ethics approval and consent to participate
This retrospective study was approved by the Rabin Medical Center Helsinki Committee (0252-20-RMC) and the Tel Aviv University Ethics Committee (0001269-3). The need for informed consent was waived due to its retrospective nature.
Consent for publication
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Shlomai, A., Ben-Zvi, H., Glusman Bendersky, A. et al. Nasopharyngeal viral load predicts hypoxemia and disease outcome in admitted COVID-19 patients. Crit Care 24, 539 (2020). https://doi.org/10.1186/s13054-020-03244-3
- Viral load